Suchergebnisse - "Porta, C"

PubPharm (491)

1

Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma : extended follow-up from the phase III randomised CheckMate 9ER trial

enthalten in: ESMO open | 2024

von Powles, T. | Burotto, M. | Escudier, B. | +17

2

Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients

enthalten in: ESMO open | 2023

von Arenare, L. | Porta, C. | Barberio, D. | +26

3

An Italian multicenter retrospective real-life analysis of patients with brain metastases from renal cell carcinoma : the BMRCC study

enthalten in: ESMO open | 2023

von Internò, V. | Massari, F. | Rudà, R. | +21

4

Salivary proteomic profile of young healthy subjects

enthalten in: Frontiers in molecular biosciences | 2023

von Dongiovanni, P. | Meroni, M. | Aiello, G. | +16

5

Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program

enthalten in: ESMO open | 2022

von Rebuzzi, S. | Signori, A. | Buti, S. | +26

6

ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2021

von Powles, T. | Albiges, L. | Bex, A. | +7

CommentIn: Ann Oncol. 2021 Dec;32(12):1466-1467. - PMID 34718116

7

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma

enthalten in: ESMO open | 2021

von Kanesvaran, R. | Porta, C. | Wong, A. | +21

8

Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis

enthalten in: Cancer treatment reviews | 2021

von Ciccarese, C. | Iacovelli, R. | Porta, C. | +5

9

Repeat partial nephrectomy for recurrence of Von Hippel-Lindau-related renal cell carcinoma in an autotransplanted kidney

enthalten in: Urology case reports | 2021

von Perri, D. | Marchioro, G. | Bondonno, G. | +3

10

First-line treatment of metastatic clear cell renal cell carcinoma : a decision-making analysis among experts

enthalten in: ESMO open | 2021

von Aeppli, S. | Schmaus, M. | Eisen, T. | +11

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[50]